- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
Translocation pathways for inhaled asbestos fibers
© Miserocchi et al; licensee BioMed Central Ltd. 2008
Received: 09 August 2007
Accepted: 24 January 2008
Published: 24 January 2008
We discuss the translocation of inhaled asbestos fibers based on pulmonary and pleuro-pulmonary interstitial fluid dynamics. Fibers can pass the alveolar barrier and reach the lung interstitium via the paracellular route down a mass water flow due to combined osmotic (active Na+ absorption) and hydraulic (interstitial pressure is subatmospheric) pressure gradient. Fibers can be dragged from the lung interstitium by pulmonary lymph flow (primary translocation) wherefrom they can reach the blood stream and subsequently distribute to the whole body (secondary translocation). Primary translocation across the visceral pleura and towards pulmonary capillaries may also occur if the asbestos-induced lung inflammation increases pulmonary interstitial pressure so as to reverse the trans-mesothelial and trans-endothelial pressure gradients. Secondary translocation to the pleural space may occur via the physiological route of pleural fluid formation across the parietal pleura; fibers accumulation in parietal pleura stomata (black spots) reflects the role of parietal lymphatics in draining pleural fluid. Asbestos fibers are found in all organs of subjects either occupationally exposed or not exposed to asbestos. Fibers concentration correlates with specific conditions of interstitial fluid dynamics, in line with the notion that in all organs microvascular filtration occurs from capillaries to the extravascular spaces. Concentration is high in the kidney (reflecting high perfusion pressure and flow) and in the liver (reflecting high microvascular permeability) while it is relatively low in the brain (due to low permeability of blood-brain barrier). Ultrafine fibers (length < 5 μm, diameter < 0.25 μm) can travel larger distances due to low steric hindrance (in mesothelioma about 90% of fibers are ultrafine). Fibers translocation is a slow process developing over decades of life: it is aided by high biopersistence, by inflammation-induced increase in permeability, by low steric hindrance and by fibers motion pattern at low Reynolds numbers; it is hindered by fibrosis that increases interstitial flow resistances.
Asbestos fibers are known to be durable and not easily digested or dissolved after being inhaled into the lung. It was reported that asbestos fibers translocate from the lung into other tissue including pleural and peritoneal tissues [1, 2]. Asbestos fibers translocated into the mesothelial tissue play an important role for the induction of asbestos related serosal disease, such as pleural and peritoneal fibrosis, as well as malignant pleural and/or peritoneal mesothelioma .
The aim of this paper is that of discussing the translocation of inhaled asbestos fibers from the lung to other body compartments based on knowledge of pulmonary and pleuro-pulmonary interstitial fluid dynamics [4–6]. Although it appears difficult to monitor the process of asbestos translocation as it takes place over decades of life, it appears useful to discuss of asbestos fibers as being dragged by bulk flows of water among compartments. We address this issue by considering the pressure gradients governing the inter-compartmental fluid exchanges, the physical features of the corresponding flows and the particular motion pattern of anisodiametric particles dragged by such flows in the tissues and across membranes delimiting the compartments.
Atmospheric asbestos pollution includes fibers whose length and diameter vary greatly according to dust formation process, distance from the source and the mineral variety of asbestos.
The cellular impact of asbestos fibers
When inhaled mineral particles establish contact with biological tissues, reactions occur depending upon chemical as well as physical properties of the fibers. In the early pathogenic response, adsorption phenomena prevail in the cell-particle interactions . Oxidation, as well as surface hydration and hydroxylation may occur in a moist atmosphere along the airways . Studies on cultured A549 cells indicate that exposure to asbestos fibers initiate free radical reactions, inhibit glucose-6-phosphate dehydrogenase activity, decrease reduced glutathione and increase leakage of the cytoplasmatic enzyme lactate dehydrogenase, a sign of plasma membrane damage. These effects indicate an increase in cellular distress upon exposure to asbestos fibers . Positively charged chrysotile fibers may bond to cell surfaces through a charge mediated effect, while amphibole fibers can bind to fibronectin . Asbestos exposure can also stimulate gene expression via intracellular signaling (MAPK cascade responds to cell surface stimuli) that governs proliferation, apoptosis and inflammation . Asbestos fibers may undergo phagocytosis by alveolar macrophages where the high concentration of oxidants and free radical release may induce chemical modifications at their surface and induce release of chemical mediators. Phagocytosis of crocidolite asbestos fibers by mesothelial cells was shown to induce intracellular oxidation, DNA strand breakage and apoptosis . Inhaled asbestos fibers produce sclerogenic and carcinogenic effects on the lung parenchyma (asbestosis and carcinoma) .
Grinding and milling affect both the form and surface composition of fibers and were shown to cause an increase in reactive oxygen species . Amphibole asbestos are the most biopersistent particles in-vivo, a property reflecting their low solubility . Solubility is increased by leaching, a process of progressive splitting of chrysotile bundles of fibers into fibrils occurring in cells, particularly in alveolar macrophages. Leaching causes an increase in chemically active surface area, and facilitates penetration of solvent molecules .
Fibers transport across the alveolar surface
An experimental model in rats has compared the pathways for translocation of insoluble particles instilled intratracheally : crocidolite asbestos fibers were found to move relatively easily through the epithelial layer as their lung interstitial burden increased sharply 24 h after inhalation, compared to inert polystyrene microspheres of the same size. Conversely, phagocytosis by alveolar macrophages remained quite low for crocidolite while it increased markedly for inert polystyrene microspheres. One would deduce from these findings that the contribution of macrophages to crocidolite fibers translocation from alveoli to lung interstitium is marginal. Phagocytosis was also demonstrated for epithelial cells. The persistence of asbestos fibers in the alveolar compartment is increased in chronic lung inflammation because of reduced clearance mechanisms through the airways .
Motion of particulate in fluid at low Reynolds number
Translocation of inhaled asbestos fibers to extrapulmonary sites has been demonstrated as "asbestos bodies" were identified by light microscopy in almost all organs . Asbestos bodies are iron coated fibers that constitute only a portion (10–30%) of the total fibers visible by light microscopy and about 1% of the fibers visible by electron microscopy .
Ambient air contains asbestos fibers and, in fact, the general population carries a "background level of asbestos in their lungs" whose burden may attain about 106 fibers/g of dry lung tissue ; for occupationally exposed people, this burden may be about two orders of magnitude higher . Asbestos fibers can potentially be dragged by bulk flows of water within and among compartments that represent porous systems where water circulates down pressure gradients. Before dealing in detail with the potential routes for translocation of asbestos fibers from the lung to other body compartments, it might be useful to consider the physical features of the motion of particulate dragged in biological fluids.
Fluid dynamic pressure gradients in physiological condition and in interstitial lung edema
In physiological conditions, pulmonary interstitial pressure ranges ~ -10 cmH2O  and a net pressure gradient exists to cause filtration from microvessels to the lung interstitium. A small pressure gradient is also present to drive water from the pleural space to the lung interstitium across the visceral pleura . Both trans-endothelial and trans-pleural flows are low due to the physiologically low permeability of these membranes [23, 24].
When interstitial lung edema develops, common fluid dynamic features occur regardless of the model of edema studied, namely: an increased plasma volume (so called hydraulic non inflammatory model), i.v. elastase injection (inflammatory model), for hypoxia exposure (a mixture of hydraulic and inflammatory model) . Following increased microvascular filtration, interstitial pressure increases from -10 up to about 5 cm H2O for a minor increase in extravascular water not exceeding 10%. Thus, interstitial lung edema represents a largely sub-clinical condition, due to the fairly low compliance of the interstitial matrix. The increased parenchymal stresses, that act as a "tissue safety factor" against further filtration, also entailed: 1) fragmentation of chondroitin and heparansulphate proteoglycans (belonging to matrix and basement membrane, respectively) due to loosening of non-covalent bonds and activation of tissue MMPs ; 2) increased expression of pro-inflammatory cytokines , 3) signalling-transduction in lung cells (mostly endothelial) in the process of matrix remodelling and deposition [27–30]. Another important consequence of the increase in interstitial pressure is the reversal of the trans-endothelial and trans-mesothelial pressure gradients allowing reabsorption of edema fluid.
The impact of asbestos exposure on lung fluid dynamics
Experimental investigations and morphological studies on workers' lungs exposed to asbestos have shown early alveolar lesions reported as "asbestos alveolitis" [12, 31] with local edema, microhemorrages and transformation of macrophages into "siderocytes". The inflammatory reaction may differ among lung regions reflecting the differences in fibers accumulation. In fact, fiber accumulation is greater in the cranial regions of the lung because the airway path to reach the alveolar compartment is shorter . In these regions, morphometric analysis revealed a modest thickening of the alveolar septa due to extracellular matrix deposition and to a mild degree of interstitial edema .
Asbestos exposure triggers production of reactive oxygen species that leads to lipid peroxidation. This, in turn, affects the expression of genes intrinsic to inflammation . Asbestos exposure also leads to depletion of extracellular superoxide dismutase thus increasing the susceptibility to reactive oxygen species . Furthermore, a condition of inflammation was demonstrated by morphometric analysis of rat lungs exposed to an asbestos dose comparable to that in the work environment . Asbestos exposure also caused an increased activity of metalloprotease MMP-9 temporally related to lung inflammatory reaction developing since day 1 after exposure. Conversely, the activity of metalloprotease MMP-2 increased at later time points (since day 7) corresponding to development of fibrosis . It appears conceivable that following activation of MMPs, the loss of integrity of the extracellular matrix would confer greater mobility to asbestos fibers thus enhancing their translocation. The myeloperoxidase status was also shown to modulate the inflammatory reaction following asbestos exposure . Asbestos exposure elicits stimulation of multiple cell-signaling pathways involving "a myriad of transcription factors and their cross-talk" , including the airway epithelial NF-kB that plays an important role in inflammatory response and cell proliferation .
In summary, the bulk of evidence indicates that asbestos exposure elicits an inflammatory reaction in the lung. Although it appears conceivable that regional differences are encountered, the highest inflammation possibly occurs at the site of fiber deposition.
Fiber translocation via pulmonary lymph flow
Trans-endothelial fibers translocation
Most of microvascular exchanges occur via the porosity of the paracellular route (pores of ~5 nm and density of ~30/μm2 and large pores of ~50 nm with a much lower density, ~1 large pore for 5000 small pores). Membrane sieving ought to be expected for any asbestos fiber whose hydrodynamic radius exceeds the size of the largest pores. The approximate hydrodynamic radius of the smallest asbestos fibers can be estimated from Stokes-Einstein relations (assuming a prolate ellipsoid shape). An equivalent radius < 50 nm can be estimated for the smallest nanoparticles with a diameter of 20 nm and a major to minor axis ratio < 5. So, the smallest asbestos particles can potentially permeate the largest endothelial membrane pores that are of about 50 nm. However, inflammation is expected to decrease steric hindrance as it increases the permeability of the endothelial barrier due to proteolysis of the intercellular link proteins mediated by the activation of metalloproteases .
Over time, the inflammatory events evoked by asbestos exposure develop towards interstitial pulmonary fibrosis and it is conceivable that deposition of fibers would result in decreased permeability of microvessels and decreased porosity of the interstitial matrix. These events cause a hindrance to water flows and, correspondingly to flow driven fibers translocation. In this condition, the action of macrophages may become of relative greater importance in the translocation process of asbestos fibers.
Trans-mesothelial fibers translocation
Primary translocation of asbestos fibers to the pleural cavity also requires a pressure gradient (black particles and black arrows in Fig. 4). As discussed above, this occurs if the degree of inflammation raises lung interstitial pressure up to ~5 cm H2O. Fiber translocation across the visceral pleura would be hindered by its thickness (~700 μm) and the prompt asbestos-induced fibrous deposition. The other route for pleural translocation of asbestos fibers is down the physiological pathway of pleural fluid formation at the parietal pleural level (shown in white in Fig. 3 and 4) . The overall resistance encountered through this pathway is relatively high as it is represented by the sum of two resistances placed in series: the endothelium plus the mesothelium . Yet, the parietal mesothelium has pores of relatively large equivalent radius, ~150–200 nm , compared to fiber hydrodynamic radius. The main pathway for pleural fluid drainage is through the lymphatic stomata of the parietal pleura and these are very abundant on the diaphragmatic surface and in the mediastinal region . Accumulation of anisodiametric particles at stomatas entrance confirms a pleural flow driven translocation of asbestos fibers and also suggest a geometric hindrance for the fibers to permeate the initial lymphatic channels (as shown in Fig. 3). Parietal pleural plaques develop at the sites of stomatal opening. Accumulation of the smallest asbestos fibers also occurs at these sites (black spots) [42, 43]. The hypothesis that pleural plaque pathogenesis is based on retrograde lymphatic drainage of asbestos fibers from the mediastinal lymph nodes to parietal pleura presently lacks a fluid dynamics based interpretation .
In the parietal pleura , only ultrathin, mostly ultrashort, fibers were observed [43, 45]. The ultrathin fibers have clearly more chances to reach the pleural compartment due to a lower steric hindrance. In this respect it is of relevance to recall that using the ashing technique, high-resolution analytical electron microscopy allowed to establish that in malignant human mesothelioma tissues about 93% of the asbestos fibers, most of them of chrysotile type, were smaller than 0.25 μm in width . The authors concluded that short, thin, asbestos fibers appear to contribute to the causation of human malignant mesothelioma. This recent view contrasts with the previous hypothesis, which was based on animal studies, that long and thin asbestos fibers (>or = 8 μm in length and < or = 0.25 μm in width) are strongly carcinogenic to induce pleural malignant mesothelioma, while shorter fibers would pose lesser risk .
The presence of asbestos fibers either free in pleural fluid or adsorbed on the mesothelial surface is likely to alter the delicate mechanism assuring pleural lubrication. Friction between pleurae is minimal under physiological conditions due to surfactant phospholipids secreted by mesothelial cells adsorbed on pleural surfaces . Hydrophobic palmitoyl chains on surfactant molecules allow reciprocal sliding by maintaining a minimum film of fluid between the pleural surfaces  due to repulsive action of negative charges and keep the coefficient of friction at a surprisingly low value (~0.02). The microfluidics of pleural fluid is critically affected by the "porosity" and "tortuosity" of the pleural space  and the existence of fibers within the pleural space or adsorbed on pleural surfaces is likely to interfere with lubrication. Furthermore, mesothelial function is likely altered either directly or indirectly by the exposure of the lung to asbestos fibers. Indeed, in an animal model of asbestos exposure  the growth phase of mesothelial cells in the visceral pleura was a very early and marked phenomenon depending upon cytokine release by lung cells, essentially unrelated to pleural fibers deposition. The same study reported that the increase in pleural macrophages in response to asbestos inhalation was 5 fold greater than that of alveolar macrophages.
Exposure to asbestos inhalation was shown to trigger cell proliferation and fibrotic deposition in the visceral pleura . Other observations in an experimental model  claim that a minimum amount of fibers could be found in pleural lavage fluid (crocidolite 0,5 μm diam, 10 μm length) after 1 week and this translocation was aided by an increase in permeability of the visceral pleura due to asbestos- induced NO formation.
Distribution of asbestos fibers was also demonstrated for the peritoneum, the pericardium and the tunica vaginalis of the testicle. Localization of fibers to the peritoneum may occur through filtration from blood capillaries of either the parietal or the visceral mesothelium. A potential route for asbestos fibers translocation between the serous cavities might be envisioned by considering that the muscular part of the diaphragm is extremely rich in lymphatic stomata both on pleural and peritoneal side, and these strain into a common submesothelial lacunar system [51, 52] although valves should prevent such fluxes .
Biopersistence of asbestos fibers in the lung
Studies on biopersistence in the lung tissue show that the half time for residence of amphiboles in the lung ranges from years to decades and they are chemically very stable, they do not fragment into shorter fibers although they can split longitudinally . The estimated half time for chrysotile is much shorter (of the order of a few months) due to leaching, macrophage removal and fragmentation. In fact, progressive fragmentation represents the reasonable interpretation for the finding that the half time of chrysotile fibers is inversely proportional to fibers size (16 days for 20 μm fiber and 107 days for < 5 μm fiber) . The long biopersistence in the lung can be attributed to fiber translocation by two routes, from the alveoli and from the blood; furthermore the development of fibrosis may result in a progressive greater hindrance to fiber translocation due to increased flow resistance of the porous interstitial matrix.
In conclusion, the translocation of asbestos fibers within the body can be interpreted as a water flow driven process aided by the high biopersistency of asbestos fibers. Given the average size and aspect ratio of the asbestos particles, it is difficult to envision their translocation through the porous extracellular interstitial space and through the membrane barriers separating compartments. On the one hand, translocation may be aided by the increase in permeability of the membranes due to asbestos-induced inflammation and by the motion features of particulates in Poiseuille flow at low Reynolds numbers; on the other, translocation is likely hindered by fibrosis that actually increases interstitial flow resistance. The net result is a slow translocation process for asbestos particles developing over decades of life.
A contribution for publication expenses comes from Fondazione Banca del Monte di Lombardia and from BONSAI FP6 European Research program.
- Suzuki Y, Kohyama N: Translocation of inhaled asbestos fibers from the lung to other tissues. Am J Ind Med. 1991, 19: 701-704. 10.1002/ajim.4700190603.View ArticleGoogle Scholar
- Dodson RF, O'Sullivan MF, Huang J, Holiday DB, Hammar SP: Asbestos in extrapulmonary sites* Omentum and Mesentery. Chest. 2000, 117: 486-493. 10.1378/chest.117.2.486.View ArticleGoogle Scholar
- Suzuki Y, Yuen SR, Ashley R: Short thin asbestos fibers contribute to the development of human malignant mesothelioma: pathological evidence. Int J Hyg Environ-Health. 2005, 208: 201-210. 10.1016/j.ijheh.2005.01.015.View ArticleGoogle Scholar
- Miserocchi G, Venturoli D, Negrini D, Del Fabbro M: Model of pleural fluid turnover. J Appl Physiol. 1993, 75: 1798-806.Google Scholar
- Miserocchi G, Negrini D: Pleural space: pressures and fluid dynamics. The Lung: Scientific Foundations. Edited by: Crystal RG, West JB Weibel ER, Barnes PJ. 1997, Philadelphia: Lippincott-Raven Pub, 1: 1217-1225. 2Google Scholar
- Miserocchi G, Negrini D, Gonano C: Direct measurements of interstitial pulmonary pressure in-in situ lung with intact pleural space. J Appl Physiol. 1990, 69: 2168-2174.Google Scholar
- Fournier J, Fubini B, Bolis V, Pezerat H: Thermodynamic aspects in the adsorption of polynuclear aromatic hydrocarbons on chrysotile and silica-possible relation to synergistic effects in lung toxicity. Can J Chem. 1989, 67: 289-296. 10.1139/v89-048.View ArticleGoogle Scholar
- Fubini B: Surface reactivity in the pathogenic response to particulates. Environ Health Perspect. 1997, 1013-1020. 10.2307/3433502. Suppl 5Google Scholar
- Riganti C, Aldieri E, Bergandi L, Fenoglio I, Costamagna C, Fubini B, Bosia A, Ghigo D: Crocidolite asbestos inhibits pentose phosphate oxidative pathway and glucose-6-phosphate dehydrogenase activity in human lung epithelial cells. Free Radic Biol Med. 2002, 32: 938-49. 10.1016/S0891-5849(02)00800-6.View ArticleGoogle Scholar
- Brown RC, Sara EA, Hoskins JA, Evans CE: Factors affecting the interaction of asbestos fiber with mammalian cells: a study using cells in suspension. Ann Occup Hyg. 1991, 35: 25-34. 10.1093/annhyg/35.1.25.View ArticleGoogle Scholar
- Robledo R, Mossman B: Cellular and molecular mechanisms of asbestos-induced fibrosis. J Cell Physiol. 1999, 180: 158-166. 10.1002/(SICI)1097-4652(199908)180:2<158::AID-JCP3>3.0.CO;2-R.View ArticleGoogle Scholar
- Liu W, Ernst JD, Broaddus VC: Pahogocitosis of crocidolite asbestos induces oxidative stress, DNA damage and apoptosis in mesothelial cells. Am J Respir Cell Mol Biol. 2000, 23: 371-378.View ArticleGoogle Scholar
- Nejjari A, Fournier J, Pezerat H, Leanderson P: Mineral fibers: correlation between the oxidizing surface activity and the DNA base hydroxylation. Br J Ind Med. 1993, 50: 501-504.Google Scholar
- Oberdöster G, Ferin J, Lehnert BE: Correlation between particle size, in vivo particle persistence and lung injury. Environ Health Perspect. 1994, 173-179. 10.2307/3432080. Suppl 5Google Scholar
- Chiappino G, Friedrichs KH, Rivolta G, Forni A: Alveolar fiber load in asbestos workers and in subjects with no occupational asbestos exposure. Am J Ind Med. 1988, 14: 37-46. 10.1002/ajim.4700140106.View ArticleGoogle Scholar
- Sjostrand M, Rylander R, Bergstrom R: Lung cell reactionsin guinea pigs after inhalation of asbestos (amosite). Toxicology. 1989, 57: 1-14. 10.1016/0300-483X(89)90030-9.View ArticleGoogle Scholar
- Trosic I, Matausic-Pisl M, Hors N: Pathways and quantification of insoluble particles in the lung compartment of the rat. Int J Hyg Environ Health. 2000, 203: 39-43. 10.1078/S1438-4639(04)70006-1.View ArticleGoogle Scholar
- Roggli VL, George MH, Brady AR: Clearance and dimensional changes of crocidolite asbestos fibers isolated from lungs of rats following short-term exposure. Environ Res. 1987, 42: 94-105. 10.1016/S0013-9351(87)80010-5.View ArticleGoogle Scholar
- Kobayashi M, Ming ZW, Watanabe H, Ohnishi Y: A quantitative study on the distribution of asbestos bodies in extrapulmonary organs. Acta Pathol Jpn. 1987, 37: 375-383.Google Scholar
- Churg A: Mineral analysis of the lung parenchyma. The Lung: Scientific Foundations. Edited by: Crystal RG, West JB Weibel ER, Barnes PJ. 1997, Philadelphia: Lippincott-Raven Pub, 2: 2325-2338. 2Google Scholar
- Gavze E, Shapiro M: Motion of inertial spheroidal particles in a shear flow near a solid wall with special application to aerosol transport in microgravity. J Fluid Mech. 1998, 371: 59-79. 10.1017/S0022112098002109.View ArticleGoogle Scholar
- Shukla A, Ramos-Nino M, Mossman B: Cell signaling and transcription factor activation by asbestos in lung injury and disease. Int J Bioch & Cell Biol. 2003, 35: 1198-1209. 10.1016/S1357-2725(02)00315-1.View ArticleGoogle Scholar
- Taylor AE, Granger DN: Exchange of macromolecules across the microcirculation. Handbook of Physiology: The Cardiovascular System. Microcirculation. 1984, American Physiological Society. Bethesda, VI: 467-520.Google Scholar
- Bernaudin JF, Fleury J: Anatomy of the blood and lymphatic circulation of the pleural serosa. The Pleura in Health and Disease. Edited by: Chrétien J, Bignon J, Hirsch A. 1985, New York: Marcel Dekker Inc, 101-124.Google Scholar
- Miserocchi G, Negrini D, Passi A, De Luca G: Development of lung edema: interstitial fluid dynamics and molecular structure. News Physiol Sc. 2001, 16: 66-71.Google Scholar
- Sabbadini M, Barisani D, Conforti E, Marozzi A, Ginelli E, Miserocchi G, Meneveri R: Gene expression analysis in interstitial lung edema induced by saline infusion. Bioch Bioph Acta-Mol Basis of Dis. 2003, 1638: 149-156.View ArticleGoogle Scholar
- Palestini P, Calvi C, Conforti E, Botto L, Fenoglio C, Miserocchi G: Composition, biophysical properties and morphometry of plasma membranes in pulmonary interstitial edema. Am J Physiol Lung Cell Mol Physiol. 2002, 282: L1382-L1390.View ArticleGoogle Scholar
- Palestini P, Calvi C, Conforti E, Daffara R, Botto L, Miserocchi G: Compositional changes in lipid microdomains of ABB plasma membranes in pulmonary interstitial edema. J Appl Physiol. 2003, 95: 1446-1452.View ArticleGoogle Scholar
- Daffara R, Botto L, Beretta E, Conforti E, Faini A, Palestini P, Miserocchi G: Endothelial cells as early sensors of pulmonary interstitial edema. J Appl Physiol. 2004, 97: 1575-1583. 10.1152/japplphysiol.00236.2004.View ArticleGoogle Scholar
- Botto L, Beretta E, Daffara R, Miserocchi G, Palestini P: Biochemical and morphological changes in endothelial cells inresponse to hypoxic interstitial edema. Respir Res. 2006, 10.1186/1 1465-9921-7-7Google Scholar
- Chiappino G, Bertazzi PA: The value of nonradiological indicators in the early diagnosis of asbestosis. IARC Sci Pub. 1980, 30: 513-515.Google Scholar
- Pinkerton KE, Plopper CG, Mercer RR, Roggli VC, Patra AL, Brody AR, Crapo JD: Airway branching patterns influence asbestos fiber location and the extent of tissue injury in the pulmonary parenchyma. Lab Invest. 1986, 55: 688-695.Google Scholar
- Janssen-Heininger Y, Poynter M, Baeuerle P: Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappa B. Free Radical Biology and Medicine. 2000, 28: 1317-1327. 10.1016/S0891-5849(00)00218-5.View ArticleGoogle Scholar
- Tan RJ, Fattman CL, Watkins SC, Oury TD: Redistribution of pulmonary EC-SOD exposure to asbestos. J Appl Physiol. 2004, 97: 2006-2013. 10.1152/japplphysiol.00480.2004.View ArticleGoogle Scholar
- Ogami A, Morimoto Y, Yamato H, Kajiwara T, Tanaka I: Patterns of histopathological change determined by the point counting method and its application for the hazard assessment of respirable dust. Inhal Toxicol. 2004, 16: 793-800. 10.1080/08958370490476749.View ArticleGoogle Scholar
- Tan RJ, Fattman CL, Niehouse LM, Tobolewski JM, Hanford LE, Li O, Monzon FA, Parks WC, Oury TD: Matrix metalloproteinases promote inflammation and lung injury in mice. Am J Respir Cell Mol Biol. 2006, 35: 289-297. 10.1165/rcmb.2005-0471OC.View ArticleGoogle Scholar
- Haegens A, van der Vliet A, Butnor KJ, Heintz N, Taatjes D, Hemenway D, Vacek P, Freeman BA, Hazen SL, Brennan ML, Mossman BT: Asbestos-induced lung inflammation and epithelial cell proliferation are altered in myeloperoxidase-null mice. Cancer Res. 2005, 65: 9670-9677. 10.1158/0008-5472.CAN-05-1751.View ArticleGoogle Scholar
- Haegens A, Barrett TF, Gell J, Shukla A, Pherson MM, Vacek P, Poynter ME, Butnor KJ, Janssen-Heininger YM, Steele C, Mossman BT: Airway epithelial NF-kB activation modulates asbestos-induced inflammation and mucin production in vivo. The Journal of Immunology. 2007, 178: 1800-1808.View ArticleGoogle Scholar
- Schlesinger RB: Clearance from the respiratory tract. Fundam Appl Toxicol. 1985, 3: 435-50. 10.1016/0272-0590(85)90091-0.View ArticleGoogle Scholar
- Dodson RF, Williams MG, Corn CJ, Brollo A, Bianchi C: A comparison of asbestos burden in lung parenchyma, lymph nodes, and plaques. Ann NY Acad Sci. 1991, 643: 53-60. 10.1111/j.1749-6632.1991.tb24443.x.View ArticleGoogle Scholar
- Wang NS: Anatomy of the pleura. Clin Chest Med. 1998, 19: 229-240. 10.1016/S0272-5231(05)70074-5.View ArticleGoogle Scholar
- Li YY, Li JC: Ultrastructure and three-dimensional study of the lymphatic stomata in the costal pleura of rabbit. Micros Res tech. 2003, 62: 240-246. 10.1002/jemt.10388.View ArticleGoogle Scholar
- Boutin C, Dumortier P, Rey F, Viallat R, De Vuyst P: Blackspots concentrate oncogenic asbestos fibers in the parietal pleura. Am J Resp Crit Care. 1996, 153: 444-449.View ArticleGoogle Scholar
- Huggins JT, Sahn SA: Causes and management of pleural fibrosis. Respirology. 2004, 9: 441-447. 10.1111/j.1440-1843.2004.00630.x.View ArticleGoogle Scholar
- Suzuki Y, Yuen SR: Asbestos fibers contributing to the induction of human malignant mesothelioma. Ann NY Ac Sci. 2002, 982: 160-176.View ArticleGoogle Scholar
- Stanton MF, Layard M, Tegeris A, Miller E, May M, Morgan E, Smith A: Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst. 1981, 67: 965-975.Google Scholar
- Hills BA: Graphite-like lubrication of mesothelium by oligolamellar pleural surfactant. J Appl Physiol. 1992, 73: 1034-1039.Google Scholar
- Miserocchi G, Venturoli D, Negrini D, Gilardi MC, Bellina R: Intrapleural fluid movements described by a porous flow model. J Appl Physiol. 1992, 73: 2511-2516.Google Scholar
- Adamson YR: Early mesothelial cell proliferation after asbestos exposure: in vivo and in vitro studies. Environ Health Perspect. 1997, 105: 1205-1208. 10.2307/3433533.View ArticleGoogle Scholar
- Choe N, Tanaka S, Xia W, Hemenway DR, Roggli VL, Kagan E: Pleural macrophage recruitment and activation in asbestos-induced pleural injury. Environ Health Perspect. 1997, 1257-1260. 10.2307/3433543. Suppl 5Google Scholar
- Negrini D, Mukenge S, Del Fabbro M, Gonano C, Miserocchi G: Distribution of diaphragmatic lymphatic stomata. J Appl Physiol. 1991, 70: 1544-1549.Google Scholar
- Miserocchi G, Negrini D, Para AF, Pistolesi M, Miniati M, Bellina R, Giuntini C: Kinetics of the intrapleural distribution of a radioactive bolus. Respir Physiol. 1986, 65: 13-27. 10.1016/0034-5687(86)90003-4.View ArticleGoogle Scholar
- Grimaldi A, Moriondo A, Sciacca L, Guidali , Tettamanti G, Negrini D: Functional arrangement of the rat diaphragmatic initial lymphatic network. Am J Physiol Heart Circ Physiol. 2006, 291: H876-H885. 10.1152/ajpheart.01276.2005.View ArticleGoogle Scholar
- Bernstein DM, Rogers R, Smith P: The biopersistence of canadian chrysotile asbestos following inhalation. Inhal Toxicol. 2003, 15: 1247-1274. 10.1080/08958370390241713.View ArticleGoogle Scholar
- Huang J, Hisanaga N, Sakai K, Iwata M, Ono Y, Shibata E, Takeuchi Y: Asbestos fibers in human pulmonary and extrapulmonary tissues. Am J Industr Med. 1988, 14: 331-339. 10.1002/ajim.4700140310.View ArticleGoogle Scholar
- Auerbach O, Conston AS, Garfinkel L, Parks VR, Kaslow HD, Hammond EC: Presence of asbestos bodies in organs other than the lung. Chest. 1980, 77: 133-137. 10.1378/chest.77.2.133.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.